Price:
Rs. 4,240.00
Sample Type: EDTA BLOOD
Fasting Not Required
Notes: N0039
Frequently Asked Questions (FAQ's):
What does the NPM1 Mutations test include?
This test detects mutations in the NPM1 gene associated with AML, using advanced molecular technology at Metropolis Healthcare.
How does Metropolis Healthcare perform the NPM1 mutation analysis?
Metropolis Healthcare uses high-precision PCR and next-generation sequencing platforms to identify gene mutations with superior sensitivity.
Who should take the NPM1 Mutations test?
Patients diagnosed with or suspected of Acute Myeloid Leukemia are recommended to undergo this test at Metropolis Healthcare for accurate diagnosis and risk classification.
Why is the NPM1 Mutations test important?
It helps determine prognosis, supports treatment planning, and is useful for monitoring therapeutic response with expert laboratory support at Metropolis Healthcare.
Do I need any preparation before this test?
No special preparation or fasting is required; Metropolis Healthcare ensures safe EDTA blood sample collection.
How soon are the results available from Metropolis Healthcare?
Results usually take a few working days, depending on the complexity of analysis and testing workflow.
Can this test help monitor treatment progress?
Yes, NPM1 mutation levels can indicate residual disease or relapse, and Metropolis Healthcare provides accurate follow-up testing for ongoing evaluation.
Is this test used along with other leukemia tests?
Yes, specialists may combine it with cytogenetic and molecular markers for comprehensive AML assessment, supported by Metropolis Healthcare’s advanced diagnostic services.